Literature DB >> 12773161

Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.

M Nellist1, M A Goedbloed, D J J Halley.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder characterized by seizures, mental disability, renal dysfunction and dermatological abnormalities. The disease is caused by inactivation of either hamartin or tuberin, the products of the TSC1 and TSC2 tumour-suppressor genes. Hamartin and tuberin form a complex and antagonise phosphoinositide 3-kinase/protein kinase B/target of rapamycin signal transduction by inhibiting p70 S6 kinase, an activator of translation, and activating 4E-binding protein 1, an inhibitor of translation initiation. Phosphorylation-dependent binding between tuberin and members of the 14-3-3 protein family indicates how the tuberin-hamartin complex may interact with upstream and downstream effectors, and suggests how phosphorylation-dependent regulation of the complex may be controlled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773161     DOI: 10.1042/bst0310587

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  14-3-3 proteins regulate retinal axon growth by modulating ADF/cofilin activity.

Authors:  Byung C Yoon; Krishna H Zivraj; Laure Strochlic; Christine E Holt
Journal:  Dev Neurobiol       Date:  2012-04       Impact factor: 3.964

Review 2.  Regulation of mTOR by amino acids and resistance exercise in skeletal muscle.

Authors:  L Deldicque; D Theisen; M Francaux
Journal:  Eur J Appl Physiol       Date:  2005-02-09       Impact factor: 3.078

3.  Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning.

Authors:  Sheng-Li Cai; Andrew R Tee; John D Short; Judith M Bergeron; Jinhee Kim; Jianjun Shen; Ruifeng Guo; Charles L Johnson; Kaoru Kiguchi; Cheryl Lyn Walker
Journal:  J Cell Biol       Date:  2006-04-24       Impact factor: 10.539

4.  Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Authors:  Sanjukta Chakraborty; S M Azeem Mohiyuddin; K S Gopinath; Arun Kumar
Journal:  BMC Cancer       Date:  2008-06-06       Impact factor: 4.430

Review 5.  Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases.

Authors:  Andrey Trulioff; Alexander Ermakov; Yegor Malashichev
Journal:  Genes (Basel)       Date:  2017-01-25       Impact factor: 4.096

6.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

7.  Signal integration in the (m)TORC1 growth pathway.

Authors:  Kailash Ramlaul; Christopher H S Aylett
Journal:  Front Biol (Beijing)       Date:  2018-07-25

8.  Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2.

Authors:  Shouwei Han; Ying Zheng; Jesse Roman
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

Review 9.  Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes.

Authors:  Terunao Takahara; Yuna Amemiya; Risa Sugiyama; Masatoshi Maki; Hideki Shibata
Journal:  J Biomed Sci       Date:  2020-08-17       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.